people faculty administrative position Okunieff, Paul, Director 2009 - faculty position Bloom, David, Member 1999 - Tan, Weihong, Faculty Member 2001 - non-academic position Bayne, Ashley Paige, Staff 2008 - Bohannon, Mary, Staff 2009 - Boyette, Robert L, Staff 2005 - Brown, Lisa Anne, Staff 2004 - Campos, Carlos G, Staff 2006 - Chadwick, Andrew, Staff 2008 - Goodenow, Maureen M., Senior Member 2001 - Hammock, Diane L, Staff 2008 - Harben, Marsha P, Staff 2004 - Ivey, Alison M, Staff 2008 - Jackson, Cynthia S, Staff 2004 - Malorzo, Wendy, Staff 2010 - Mintz, Dona-Marie, Staff 2010 - Moore-Higgs, Giselle J, Staff 2008 - Murphy, Terry Lynn, Staff 2009 - Pettiford, Leslie C, Staff 2008 - Praither, Denise M, Staff 2009 - Price, Marie L, Staff 2009 - Ritari, Kellie L, Staff 2008 - Rogers, Heather Bergman, Staff 2009 - Snyder, Crissy Ann Greene, Staff 2004 - Tyler, Greg, Staff 2004 - Veal, David Holiday, Staff 2008 - Veal, Margaret A, Staff 2008 - position Anderson, Ashley, Research Programs/Services, Coordinator 2 2008 - Anderson, Patrick A, Clinical Programs, Coordinator 1 2015 - Bayne, Ashley Paige, Registered Nurse Specialist 2005 - Brandao, Marcela, Development/Alumni Affiliate, Coordinator 1 2013 - Brown, Lisa Anne, Research Programs/Services, Coordinator 4 2000 - Chan A Shing, Terry F, Registered Nurse Specialist 2002 - Cline, Christina L, Registered Nurse Specialist 2004 - Currie, Jessica Ryan, Development/Alumni Affiliate, Coordinator 1 2014 - Earl, Vickie Ann, Research Programs/Services, Coordinator 3 2015 - Gebhardt, Diane, Administrative Assistant 2005 - Hammock, Diane L, Grants Specialist, Senior 2006 - Harada, Naho, Research Programs/Services, Coordinator 3 2015 - Huysman, Brynn, Development/Alumni Affiliate, Coordinator 1 2010 - Ivey, Alison M, Registered Nurse, Senior Supervisor 2005 - Jackson, Cynthia S, Grants Specialist Supervisor 1976 - Jackson, Cynthia S, Accounting, Coordinator 2 1976 - Jin, Shouguang, Member 2001 - Jones, Stephanie A, Fiscal Assistant, Senior 2012 - Jones, Stephanie A, Administrative Assistant 2012 - Lewis, Melissa A, Program Assistant 2010 - Malorzo, Wendy, Grants Specialist, Senior 2010 - Mccall, Marjorie D, Registered Nurse Specialist 2015 - Morales, Daniel J, Program Assistant 2005 - Murphy, Terry Lynn, Program Assistant 2007 - Nimitz, Carol B, Development/Alumni Affiliate, Director 5 2013 - Pettiford, Leslie C, Registered Nurse, Senior Supervisor 2007 - Pettiford, Leslie C, Registered Nurse Specialist 2007 - Pittman, Joseph F., Program Assistant 2007 - Praither, Denise M, Program Assistant 2003 - Richardson, Diane, Program Assistant 2007 - Rinc, David A, Storekeeper/Receiving Clerk 2012 - Rodriguez, Cecilia, Administrative Services, Coordinator 3 2003 - Rodriguez, Cecilia, Administrative Services, Coordinator 2 2003 - Rogers, Heather Bergman, Registered Nurse Specialist 2009 - Sawicki, Barry C Mr, Program Assistant 2011 - Scurlock, Belinda R, Grants Specialist, Senior 2007 - Sevier, Brian J, Research Programs/Services, Associate Director 5 2000 - Shaffer, Joshua A, Administrative Services, Coordinator 2 2007 - Shapiro, Alexandra M, Research Programs/Services, Coordinator 3 2014 - Stokes, Joe, Research Programs/Services, Assistant Director 4 2001 - Taylor, Tracey Harris, Registered Nurse Specialist 2015 - Terrell, Joshua Nicholas, Clinical Programs, Coordinator 1 2013 - Tormes, Kevin Jorge, Registered Nurse Specialist 2012 - Trainor, Allison Beth, Research Programs/Services, Coordinator 2 2009 - Tucker, Caitlin D, Registered Nurse Specialist 2015 - Tyler, Greg, Facilities Planning, Coordinator 3 1999 - Veal, David Holiday, Research Programs/Services, Coordinator 2 2008 - Veal, David Holiday, Grants Specialist 2008 - Veal, Margaret A, Program Assistant 2007 - Wu, Lizi, Member 2006 -
has sub-organization Hematology and Oncology UF Health Cancer Center Biostatistics Core UF Health Cancer Center Structure-based Drug Design Lab UF Health Cancer Center at Orlando Health
convener of event Center for NeuroGenetics Meeting Dr. Craig Lindsley Seminar Dr. Milton Brown Seminar Dr. Said Sebti Seminar Genetics Genomics Grad Meeting Genetics Grad Meeting Kyungsuk Choi's Final Defense Ocala Royal Dames Luncheon Research in Progess Meeting-CMT Summer Science Institute Weihong Tan Research Group Meeting
awards grant Carbonic Anhydrase Ix Experimental Therapeutics Working Group Microrna-Mediated Gene Silencing in Kshv-And Ebv-Associated Malignancies Molecular Mechanism of Asparaginase Action Viral-Based Chemokine Receptor Antogonists: Targeting Microglial Expressed Cx3cri As a Novel Therapeutic Approach for Th
administers grant (Acosog) Z9001: Phase III Randomized Double-Blind Study of Adjuvant St1571 (Gleever Tm) Vs Placebo in Patients Following the (Bmtu) Miscellaneous Donors ...Aflibercept...2 Wks Vs Placebo in Patients W/ Metastatic Colorectal Cancer (Mcrc) Treated W/Irinotecan/5-Fu Comb... ...Chemotherapy/Chemoradiotherapy With/Without Hyperacute - Pancreas Immunotherapy in Subject With Surgically Resected... ...Ezn-3042, a Survivin Mrna Antogonist, Administered With Re-Induction Chemotherapy in Children With Relapsed...(All) ...Phase 2 Study of Single-Agent Erlotinib V. Oral Etoposidein Patients C Recurrent or Refractory Pediatric Ependymome ...Vorinostat (Mk-0683) or Placebo in Combination With Bortezomib in Patients With Multiple Myeloma 0201 Adderall-Xr Tm Versus Concerta Tm for Cancer Treatment-Related Neurocognitive Sequele And 0205 - the Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With 0205 - the Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With 0502: Phase Ii Rndmzd Prlel Plcb-Cntrld Dbl-Bl Multictr Effi and Saf Stdy of Ramoplanin and Plcb in Neutropenic Oncology..... 30 Day Open Label Active Controlled Randomized Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic 9238Il/0048:...Fulvestrant Vs. Exemestane in Postmenopausal Women With...Breas Cancer..Ai Therapy A 5-Year, Prospective, Non-Interventional Multicenter Registry in Sickle Cell Disease Patients A Clinical Study to Demonstrate Safety and Efficacy of E7777(Denileukin Diftitox) in Persistent or Recurrent Cutaneous A Clinical Trial Comparing Preoperative Radiation Theraphy & Capecitabine With or Without Oxaliplatin Withpreoperative.. A Double-Blind.Placebo-Controlled,Multictr,Randomized Study Evaluating the Prophylactic Use of Pegfilgrastim on the .... A Feasibility Study Investigating Translational Science in Chemotherapy Naive Patients With Stage Iiib or IV Non Small.. A Multi Center Phase 1 Study of Intravenous Deforolimus (Ap23573,Mk-8669) Administered Qdx5 Every Other Week in ........ A Multi Center Randomized Controlled Three Arm Phase III Study to Evaluate the Safety and Efficacy of Two Dosing..... A Multicenter Open-Label, Randomized Phase 1B/2, Study of Brutons Tyrosine Kinase (Btk) Inhibitor, Ibrutinib, in Comb A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Fk228 in Patients That A Multicenter, Randomized, Db, Plcb-Cntld, Comparative Trial of AMD3100 Versus G-Csf Plus Placebo to Mobilize and Collect A Multicenter, Randomized,Db, Plc-Ctld, Comp Trial of AMD3100 Plus G-Csf Vs G-Csf Plus Placebo to Mobilize and Collect A Non-Interventional Follow-Up to the Velour Study (Multicenter International Study of Aflibercept Versus Place A Non-Interventional Retrospective Correlation of Tumor Mutation Status to Clinical Benefit From the Su011248 A Phase 1 Dose Escalation Study of Omp-52M51 in Subjects With Lymphoid Malignancies A Phase 1/2 Study to Assess the Safety and Efficacy of Lorvotuzumab Mertansine (Imgn901) in Combination With . . . A Phase 11 Trial of Bortezomb Plus Doxorubicin in Hepatocellular Carcinoma A Phase 1B, Multi-Center, Open-Label, Dose Finding Study of Cc-122 in Combination With Sorafenib in Subjects With . . . A Phase 1B/2 Randomized Phase 2 Study Evaluating the Evaluating the Efficacy of Doxorubicin With or Without..... A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With Mfolfox6 to . . . A Phase 2/3, Multi-Center, Open Label Study of Efficacy, Safety, and Pharmacokinetics of Pegylated Recombinant Factor A Phase 3 Multi Center Randomized Double Blind Placebo Controlled Parallel Group Study to Compare Efficacy and Safety A Phase 3 Prospective, Uncontrolled, Multicenter Study Evaluating Pharmacokinetics,Efficacy,Safety..... A Phase 3 Randomized Study of the Efficacy & Safety of Posaconazole Versus Voriconazole for the Treatment.......... A Phase 3 Randomized, Open-Label Study Evaluating Dn-101 in Combination With Docetaxel in Androgen-Independent Prostate A Phase 3, Double-Blind Extension Study Evaluating the Efficacy and Safety of Two Different Dose Levels...... A Phase 3, Multi-Center, Open Label Study of Efficacy and Safety of Pegylated Rfviii (Bax855) in Previously Treated . A Phase 3, Multicenter, Open-Label, Randomized Study of Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone... A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide (Pom)... A Phase 3, Randomized Double Blind, Multicenter Study Comparing Oral Mln9708 Plus Lenalidomide and Dexamethasone.. A Phase 3, Randomized Study to Evaluate the Efficacy of Momelotinib Versus Best Available Therapy in Anemic or A Phase 3, Randomized, Dbl-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Gs-1101 (Cal-101)..... A Phase 3, Randomized, Double-Blind, Placebo-Controlled Evaluating the Efficacy and Safety of Gs-1101 (Cal-101)... A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Orbec..... A Phase 3B Continuation Study of the Safety and Efficacy of Pegylated Recombinant Factor Viii (Peg-Rfviii; Bax 855) A Phase I Dose Finding Study of Panobinostat in Children With Refractory Hematologic Malignancies A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide A Phase I Window, Dose Escalating & Safety Trial of Metformin in Combination With Induction Chemotherapy in Relapsed.... A Phase I, Open Label Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Oral Doses A Phase I/II Dose-Escalation Study Evaluating the Combination of Neratinib and Cetuximab in Patients . . . A Phase II Clinical Trial of Four Cycles of Doxorubicin and Cyclophosphamide Followed By Weekly Paclitaxel Given........ A Phase II Clinical Trial of Lenalidomide and Prednisone in Low and Imtermediate-1 Ipss Risk, Non-Del (5Q) Mds Patients A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Docetaxel in Combination With 1-Methyl-D-Tryptophan A Phase II Multicenter Open Label Single Arm Study of Sar302503 in Subjects Previously Treated With Ruxolitinib... A Phase II Randomized Controlled Trial of Genomically Directed Therapy After Preoperative Chemotherapy.... A Phase II Randomized Study Comparing Two Doses of Carfilzomib (Nsc0756640) With Dexamethasone for Multiple A Phase II Study of Avn944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer A Phase II Tiral of Perifosine in Patients With Chemo- Insensitive Sarcomas A Phase II Trial of External Beam Radiation Therapy and Cetuximab Followed By Irinotecan and Cetuximab for Children..... A Phase III Randomized Clinical Trial of Pembrolizumab (Mk-3475) Versus Paclitaxel, Docetaxel or Vinflunine.... A Phase III Randomized Double Blind Placebo Controlled Study to Evaluate the Efficacy and Safety of Prochymal .......... A Phase III Randomized Double-blind Study of Induction (Daunorubicin/Cytarabine)and Consolidation (High Dose Cytarabin A Phase III Randomized Open-Label Study Comparing Gemcitabine Plus Cetuximab (Imc-C225) Versus Gemcitabine As First..... A Phase III Randomized Study of Adjuvant Ipilimumab Anti-Ctla4 Therapy Versus High-Dose Inteferon Alfa-2B for Resected H A Phase III Randomized Study of Oral Sapacitabine in Elderlypatients With Newly Diagnosed Acute Myeloid Leukemia A Phase III Randomized Trial for Patients With De Novo Aml Using Bortezomib (Ind# 58443, Nsc# 681239) and Sorafenib... A Phase III Randomized, Double-Blind Study of Maintenance the Therapy With Cc-5013 (Nsc- 713813, Ind- 70116.Non-Fed A Phase III Study of Chemotherapy With or Without Algenpantucel-L (Hyperacute-Pancreas) Immunotherapy in ..... A Phase III, Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Node-Positive Breast Cancer: A Phase III, D/B, R/D, Placebo-Ctrl, M/C Clinical Trial to Study the Safety, Tolerability, Efficacy, & Immu of V212.... A Phase III, Open Label, Randomized Study of Azd9291 Versus Platinum-Based Doublet Chemotherapy for Patients With ... A Phase III, Open Label, Randomized, Multicenter Trial of Ofatumumab Maintenance Treatment Versus No Further..... A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 ... A Phase III, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal (Ex-Viv A Phase III, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of the Efficacy, Safety, and A Phase Ib Study of the Safety and Tolerability of Ruxolitinib in Combination With Gemcitabine With or Without A Phs 2 Study of Sta-4783 in Combination with Weekly Paclitaxel for Treatment of Patients C Soft Tissue Sarcomas A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 2-Parallel Group, Phase III Study To.... A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to That Of.... A Randomised Phase III Study of Elacytarabine Vs. Investigator's Choice in Patients With Late Stage Acute . . A Randomized Controlled Open Label Phase 2 Trial of Sgi-110 and Carboplatin in Subjects With Platinum-Resistant ........ A Randomized Double Blind Placebo Controlled Trial to Evaluate the Safety, Tolerability and Antiviral Activiral........ A Randomized Open-Label Phase III Trial of Decitabine (5-Aza2-Deoxycytidine) V. Supportive Care in Adults W/Advanced A Randomized Phase II Study of Mk-3475 Versus Chemothereapy in Patients With Advanced Melanoma A Randomized Phase II/III Study of Paclitaxel/Carboplatin Metformin (Nsc#91485) Versus Paclitaxel/Carboplatin/Placebo A Randomized Phase III Multicenter Trial of Gemcitabine in Combination With Carboplatin or Paclitaxel Vs Paclitaxel Plus A Randomized Phase III Study of Standard Cytarabine Plus Daunorubicin (7+3)Therapy or Idarubicin With High Dose...... A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Plus Cyclophosphamide Followed By Weekly Paclita A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients With Met... A Randomized Single Blind Study :Extracorporeal Photoimmune Therapy /Uvadex in Conjunction W/Standard Therapy for ... A Randomized Trial of the Combination of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and . . . A Randomized, Double-Blind, Placebo-Controlled Study of the Jak Inhibitor Incb018424 Tablets Administered Orally....... A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Brentuximab Vedotin and Chp (A+Chp) Versus Chop........ A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional Phase Ii.5 Study of Saracatinib (Azd0530 A Randomized, Multicenter, Open-Label Phase III Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine... A Randomized, Open-Label Phase 3 Study of Carfilzomib, Melphalan, and Prednisone in Transplant-Ineligible.... A Randomized, Open-Label, Multicenter, Phase 2 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel Versus . A Rmd, Prospective, D/B, Placebo-Controlled, Phase 3 Study of US-Atg-F Prophylaxis As a Supplement to Standard of Care A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor Who Are Ineligible for Participation in Other. AMD3100-3101-Ltf Long-Term Obsrvtnal Flw-Up Study of Multi-Center Randomized 2-Blnd Plcb-Ctrl Comptrl of AMD3100 + G-Csf Vs ... AMD3100-3102-Ltf Long-Term Obsrvtnal Flw-Up Study of Multi-Center Randomized 2-Blnd Plcb-Ctrl Comptrl of AMD3100 + G-Csf Vs ... Access Program With Denileukin Diftitox for the Treatment Ofpatients Currently Receiving Treatment With Commercially Acute Gvhd-1: a Randomized, Controlled, Parallel-Group, Multicenter Study of Extracorporeal Photoimmune Therapy..... Adult Hsc Provide Hemangloblast Activity American Cancer Society-Transcriptional Regulation of Snail/Slug and Its Implications in Cancer An Exploratory Phase Ii, Multi-Ctr Open-Label Trial Evauating the Activity and Tolerability of Fk228 in Androgen Indepen An Open Label Multi Centre Randomized Phase II Study to Investigate the Safety and Tolerability of Ro5072759........ An Open Label Phase 1 Study of R-Cvp or R-Gdp in Combinationwith Inotuzumab Ozogamicin in Subjects With Cd22-Positive An Open Label Randomized Controlled Dose Escalating Phase Phase Dy of As1411 Combined With Cytarabine in The....... An Open-Label Expanded Access Study of Tas-102 in Patients With Metastatic Colorectal Cancer Refractory to or Failing.. An Open-Label Phase I Study of the Safety and Efficacy of Gcs-100 in Subjects With Releapsed or Relapsed/Refractory Mult An Open-Label Randomized Phase 3 Study of Inotuzumab Ozogamicin Compared to a Defined Investigator's Choice in An Open-Label Randomized Study to Develop a Screening Tool for Funtional Capacity in Anemic Subjects W.Nonmyeloid Malig An Open-Label Study of the Efficacy, Safety, and Tolerability of Oral Scio-469 in Trearment of Relapsed, Refractory ...... An Open-Label, Cross-Over, Pharmacokinetic Study to Assess the Safety and Pharmacokinetics of Transdermal Granisetron-- An Open-Label, Multicenter, Randomized, Phase III Study to Efficacy and Safety of Bendamustine Compared With...`- An Open-Label, Randomized Phase Iib/III Active Control Studyof Second-Line Hyperacute-Lung (Tergenpumatucel-L) .... An Open-Label, Randomized, Phase 3 Study of Inotuzumab Ozogamicin Administered in Combination With Rituximab Analysis of Pu1 Function in Hematopoiesis Barney Fund for Research Projects to Benefit Public Bcx-1777-T-04-201 a PHS 2 Multi-Center Opn-Lbl Representative-Dose Study of Forodesine Hydrochloride Infusion in Patients W Advanced... Bone Marrow and Stem Cell Program Support Braca - 1/2/ Genetic Testing Breast Cancer Research Breast Cancer Research COG Grant: Industry Funds: a Phase 2 Multi-Center, Historically-Controlled Study of Dasatinib Added to . . . Ca225006: ...Irinotecan and Cenuximab Vs. Irinotecan As 2nd-Line Treatment...Egfr-Positive Colorectal Carcinoma Cancer Research At Ufscc Cc-5013...Plus Dexamethasone Vs. Dexamethasone Alone In... Subjects With Multiple Myeloma Cdc Pa 00055: Surveillance of Invasive Fungal Infections Inbone Marrow/Stem Cell and Solid Organ.... (Ur3/Ccu419282-01) Chagnon Professorship - Research in Field of Stem Cell Biology & Bone Marrow Transplantation for Christopher Cogle Childrens Oncology Group Chairs Grant Per Case & Speciman Agreement Chop Work Order - St. Baldricks Foundation Supplemental Reimbursement Clinical and Economic Impact of Upfront Plerixafor in Autologous Transplantation Collection of Blood Samples From Patients With Chronic Lymphocytic Leukemia: a Laboratory Research Protocol Com 1.3: Eval of Immunol Oral Rinse for the Mgmt of Oral Mucositis in Cancer Patients Undergoing Radiation And/Or .. Comparative Analysus of Cell Death Regulation in Mosquitoes Connect Mds/Aml Disease Registry Cooperative Group Outreach Program- E2902-Acute Myeloid Leukemia Davis Cancer Endowment Davis Cancer Research Defining the Hemangioblast in Tumor Neoangiogenesis Defining the Human Hemangioblast Deflect-1: a Phase 3B Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate . . . Development of Small Molecule Anti-Leukemia Drugs Development of a Structure-Based Small Molecule Anti-Lung Cancer Drug(S) By Trageting Bax Dfci Protocol 09-001-a Phase II Study of Rad001 (Everolimus)for Children With Chemotherapy Refractory Progressive..... E1200- Randomized Phase Ii Study of Gemcitabine Plus Radiotherapy Vs. Gemcita E1201- a Randomized Phase Ii Study in Operable Adenocarcinoma of the Esophagas to Measure Response Rate and Toxicity.... E1302: Phase III Randomized, Placebo Controlled, Trial of Docetaxel Versus Docetaxel Plus Zd1839...... E1305: a Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or . . . E1900 - a Phase III Trial in Adult Acute Myeloid Leukemia: Daunorubicin Dose-Intensification & Gemtuzumab-Ozogamicin... E1A00: a Randomized Phase III Trial of Thalidomide (Nsc#66847) Plus Dexamethasone Verses Dexamethasone in Newly Diag.... E2603 a Double-Blind, Randomized, Placebo-Controlled Phase III Trial of Carboplatin, Paclitaxel and Bay 43-9006 Versus E2A02 - Pahse II Study of Ps-341 for Patients With High-Risknewly Diagnosed Multiple Myeloma. E3999 a Randomized, Placebo-Controlled Double Blind Trial of the Administra..... E4A03-a Randomized Phase III Study of Cc-5013..... Ecog - E3200- Phase III Trial of Bevacizumab (Nsc 704865), Oxaliplatin (Nsc 2666046), Fluorouracil and Leucovorin Vs Egf 30008 a Randomized Dbl-Bl Plcb Cntrld Multictr Phase II Stdycomparing Gw72016 & Letrozole Vs Letrozole in Subject W/ Estro Expanded Access of Mk-3475 in Metastatic Melanoma Patients With Limited to No Treatment Options Expedited Indian River Evaluation of Tetrazyg Rootstocks Surviving the HLB-Gauntlet Fiqcc - Florida Initiative for Quality Cancer Care Fiqcc - Florida Initiative for Quality Cancer Care (Protocol 2) G2000-03:a Phase Trial to Evaluation the SAF and Effic of Specif Immunotherapy,Recombinant Idiotype Conjugated to Klh ... Gammacell 40 Exactor Research Irradiator Glactomannan Enzyme Linked Immunoassay As an Early Diagnostic Test for Invasive Aspergillosis in Patients Gm-Csf Treatment After High-Dose Chemotherapy (Hdc) and Autologous Stem Cell Transplantation (Asct) for Lymphoma... Gm-Csf and Interferon Maintenance Therapy for Multiple Myeloma Patients After Autologus Stem Cell Transplantation (Asct) Health Effects After Anthracycline & Radiation Therapy (Heart): Dexrazoxane and Prevention (Lls Support) Holloway Breast Cancer Research Holloway Research Support for Breast Cancer At Ufscc Identification of Genes for Conditional Lethality of Insect Pest Species Il-3 Growth Factor Signaling Il-3 Growth Factor Signaling Industry Funds: Intergroup Trial for Children or Adolescentswith B-Cell Nhl or B-Al: Evaluation of Rituximab Efficacy... Industry Funds: a Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-All) . . . Industry Support for Assure: Adjuvant Sorafenib or Sunitinibfor Unfavorable Renal Carcinoma Innes Professorship in Cancer Research Involvement of Apc in DNA Repair Irwin Cancer Research Equipment Krumins Fund for Stomach Cancer Reserch At Ufscc Kshv-Encoded Micrornas Lana and the Celular Gene Expression in Kaposi's Sarcoma Leica Tcs Sp5 Aobs Confocal Microscope With Tandem Scanner Leukemia Research Equipment Lung Cancer Research Mechanisms of Secondhand Smoking-Unduced Breast Carcinogene-Sis Medicine Consolidated Research Microrna-Mediated Gene Silencing in Kshv-And Ebv-Associated Malignancies Mlti Ctr Open Ended Dble Blnd Plcbo Contrlled Phse 3 Stdy Ofae-941 in Addition to Combined Modality Trtment (Chemo/Radi Mmf Study: ...Mycophenolate Mofetil Added to Prednisone Pluscyclosporine or Tacrolimus...Protocol No. 1697 Mondello Support for Cancer Research At Ufscc Multicenter Phase II Study of Nonmyeloablative Allogeneic Stem Cell Transplantation Using Matched Unrelated Donor..... Multicenter, Open-Label, Active-Controlled, Randomized Studyto Evaluate the Efficacy and Safety of An Age and Body Multicenter, Open-Label, Randomised, Pharmacokinetic (Pk)Andpharmacodynamic (Pd) Dose-Ranging Phase II Study of .... Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Fulvestrant (Faslodex With or Without Pd Ncctg N0147 - a Randomized Trial of Irinotecan(Cpt-11) and/or Oxaliplatin (Oxal) Plus 5 - Flurouracil (T-Fu) / Leucovor Nicotine Reg of Baxs Proapoptotic Function in Human Lung Cancer Cells Nicotine/Nnk Signaling in Human Lung Epithelial and Lung Cancer Cells No16966 an Open-Lbl Rndmzd Phase III Stdy of Intermittent Oral Capecitabine in Combination W/ Intravenous Oxaliplatin Nsabp B-35 a Clinical Trial Comparing Anastrozole With Tamoxifen in Postmenopausal Patients With Ductal Carcinoma.. Nsabp Biospecimen Discovery Project (Dp-1) Nsabp Patient Registry and Biospecimen Profiling Profiling Repository Nsabp-42 Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients ........... Nsabp-46-I a Phase III Clinical Trial Comparing the Combination of Tc Plus Bevacizumab to Tc Alone, and to Tac.. Ocala Royal Dames Visiting Lectureship Oncology Nurse Education and Certification Open Label, Single Arm Study of the Safety and Efficacy of Cc-5013 Monotherapy for Subjects With Multiple Myeloma: Open Labeled, Non-Comparative Treatment Protocol for the Useof Sorafenib in Patients With Advanced Renal Cell Carcinoma Open-Label, Limited Access Protocol of Posaconazole in Invasive Fungal Infections Opn-Lbl Sgl-Arm Mlti-Ctr Phs2 Stdy of Troxatyl...Admin by Cont Infusion in Pts C Acute Myeloid Leukemia...In 2nd... Osteonecrosis of the Jaw (Onj) Case Registry Oti-010 Protocol #240: a Phase Ii Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy P04086 - Phs1/2 Trial of Temozolomide & Escalating Doses of Oral Vice President-16 for Children & Young Adults C Rec Brain Tumors PHS 1 Study of Erbitus (Cetuximab) in Ped Subjs C Refractory Solid Tumors: Char of Serum Pharmokinetics, SAF/Eff... Pacct-1: Program for the Assessment of Clinical Cancer Test Trial Assgn. Indvl. Options for Treatment: the Tailorx Trial Pancreatic Cancer Research Phase 1, Traditional 3+3, Trial of Sorafenib and Topotecan in Refractory or Recurrent Pediatric Solid Malignancies Phase 1B/2, Multicenter, Open-Label Study of Carfilzomib, Carboplatin, and Etoposide in Subjects With Previously Phase 2 Open-Label Study of Amonafide L-Malate in Combination With Cytarabine in Subjects With Secondary ..... Phase 2 Study of Safety & Efficacy of Nimotuzumab in Pediatric Patients With Recurrent Diffuse Intrinsic Pontine Glioma Phase 2/3: Study of Docetaxel in Combination with Cisplatin (Cddp) or Docetaxel in Combination W/5-Fluorouacil (5-Fu)... Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (Drd) Vs Lenalidomide and Dexamethasone....... Phase I Dose-Escalation Trial of Clofarabine Followed By Escalating Doses of Fractionated Cyclophosphamide In...... Phase I, Open Label, Clinical Study to Determine the Maximumtolerated Dose (Mtd) of Oral Dovitinib (Tki258) When Given.. Phase I/II Study of Krn330 Plus Irinotecan After 5-Fluorouracil, Leucovorin, and Oxaliplatin (Folfox) Failure in Patient Phase II Study of 5-Fluorouracil, Oxaliplatin Plus Dasatinib(Folfox-D) in First-Line Advanced/Metastatic Pancreatic Phase II Study of Sequential Gemcitabine Followed By Docetaxel for Recurrent Ewings Sarcoma, Osteosarcoma,...... Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated..... Phase II Trial of Neoadjuvant Capecitabine W/ Hyperfraction Accelerated Radiation Thrpy in Locally Advanced Rectal Cance Phase III Adjuvant Trial of Sequenced Ec+Filgrastim+Epoetin Alfa Followed By Paclitaxel Versus Sequenced Ac Followed By Phase III Multicenter Randomized Trial of Cpx-351 Cytarabineand Daunorubicin in Patients 60-75 Years of Age With ....... Phase III Randomized Trial of Clofarabine As Induction and Post-Remission Therapy Vs. Standard Daunorubicin & . . . Phase Ib Study of the Safety, Tolerance & Phrmacokinetics Oforal Posaconazolen in Immunocompromised Children With ... Phase, I, Dose-Finding Study of Rituximab..For Relapsed and Refractory Non-Hodkins Lymphoma Phasee II/III Trial of Neoadjuvant Folfox With Selective Useof Combined Modality Chemoradiation Versus Preoperative.... Phs1/2 Multi-Center Opn-Lbl...Study of Forodesine Hydrochloride Infusion in Pts C B-Cell Acute Lymphoblastic Leukemia C... Pilot Trial of 2 Dose Levels of Thymoglobulin As Part of a Myeloablative Conditioning for a Hla Indentical Matched Rela Pkc- Expression on the Outcome of Chemotherapy Po1899-38 a Randomized Controlled Trial of Posaconazole (Sch 56592) V. Standard Azole Therapy for the Prevention Of Post-Transcriptional Gene Regulation By Ebv Sm Protein Probing the Complexity of Uv Unduced Apoptosis in Drosophila Prospective Observational Study of Mylotarg in Usual Care Prostate Cancer Prevention Trial Prostate Cancer Research At Ufscc Prot#:799 Onc 9041 0177: a Randomized Trial on the Efficacy of Non-Cross Resistant, Consolidation Therapy V High Dose Cy Protocol #104864/535: a Phase Ii Trial of Twice Daily Oral Topotecan As a Radiation Sensitizer W. Twice Daily Radiother Protocol 1777bc-102 a Phase I Multi-Center Study of Intravenous Bcx-1777 in Patients with Refractory T-Cell and Non-T-Ce Randomized 2X2 Multi-Center, Opn-Lbl Ph2 Study of Bms-354825 Admn Oralat Dose of 50Mg or 70Mg 2X Daily or 100 Mg or 140 Mg Once... Randomized Double Blind Multicenter Phase 3 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo.... Randomized Open Label Phase 3 Study of Pemetrexed Plus Carboplatin Followed By Maintenance Pemetrexed Versus Paclitaxel Randomized Open-Lbl Phs2 Trial Comp Rituximab + Sargamostin to Rituximab Monotherapy for Trtmnt of Relapsed Follicular... Randomized Opn-Lbl Ctrl Clinical Trial of Chemo & Bevacizumab W &W/Opanitumumab in the First-Line Trtmnt of Subject W Metastatic... Randomized Phase 3 Trial of Decitabine Versus Patients Choice With Physicians Advice of Either Supportive Care Or...... Randomized Phase II Trial of Single Agent Mek Inhibitor Trametinib (Gsk1120212) Vs...(Non-Federal Industry Project) Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens for Patients With Low Tumor Burden Indolent Randomized Phase Iii Study Comparing Conventional Dose Treatment Using A Combination Of Lenalidomide, Bbortezomib.. Randomized Study of Cloretazine and Cytosine Arabinoside (Arac) in Patients With Acute Myeloid Leukemia in First Relapse Rdmzd 2-Arm Mltictr Opn-Lbl Phs2 Stdy of Bms-354825 Adm Oralat Doseof 70mg 2x Pd or 140mg 1x Pd in Subj C Chronic... Rdmzd Mlti-Ctr Opn-Lbl Mod Dose-Ascen Prll Stdy of Safety, Tol, Eff of Oral Scio-469 in Pts W Myelodysplastic Syndrome Re Gist Ry Retrospective Chart Review to Evaluate Practice Patterns Andoutcomes Among Patients With Multiple Myeloma....... Rinker Chair Role of Kos in Regulating Cell Growth Role of Notch Signalling in Transformation of Epithelial Cell By E6 Oncogene Role of Pke—r in a Novel Il-3 Signal Transduction Pathway Roles of the Mamli Courtesy-Activator in Myogenesis and Muscular Cdstrophy S1207 Phase III Randomized Placebo Controlled Clinical Trialevaluating the Use of Adjuvant Endocrine Therapy +/- One Yea Safety and Efficacy of Nnc 0155-0000-0004 in Prevention and Treatment of Bleeds in Paediatric Previously Untreated Salkewicz Fund for Leukemia Research Scios 469-B006 Seed Awards and Personnel Appointments - Innes Professorship Single Agent Adjuvant Aflibercept (Ziv-Aflibercept) for Patients With Resected or Ablated Metastatic Colorectal..... Single-Dose Pilot Study of Oral Rivaroxaban in Pediatric in Pediatric Subjects With Venous Thromboembolism Small Cell Lung Cancer Therapy Using Targeted Radiation Along With Chemotherapy & Use of Aptamersto Detect Small . . Sorafenib Plus Capecitabine (Sorcape) in Previously Treated Metastatic Colorectal Cancer Sponholtz Family Cancer Research Fund -#F14006 St. Baldrick's Foundation Stomach Cancer Research Equipment Streiff Blood Cancer Research Study of a Short Course of Neoadjuvant Gleevec (Imatinib Mesylate in Dermatofibrosarcoma Protuberans Support Bronchioloalveolar (Bac) Lung Cancer Research Support Cancer Care Coordinators and Patient Navigators Support of Lymphoma Research At UF Shands Cancer Center Support of Women's Cancer Research Targeting Genomic Instability in Myelodyplastic Syndrome Targeting Lana Function to Develop Kshv Antivirals The Clinical Research on Transplantation of Umbilical Cord Stem and Progenitor Cells The Florida Initiative for Quality Cancer Care (Fiqcc) (Protocol 3) The Health Literacy of Young Adult Cancer Survivors The Role of Bad in Nicotine/Nnk Signaling Pathways in Human Lung Cancer Cells The Role of Bc12 in Nicotine-Induced Survival Signaling and Chemoresistance in Human Lung Cancer Cells The Role of Pkr in a Novel Il-3 Signal Transduction Pathway The Role of Sdf-1 in Hemangioblast Activity The Role of Sdf-1 in Hemangioblast Activity The Role of Sdf-1 in Hemangioblast Activity Training Grant in Cancer Biology Training Grant in Cancer Biology Tumor Suppressor Apc and Breast Carcinogenesis UF Health Cancer Center Bridge Seed Grant UF Health Cancer Center Collaborative Seed Grant UF Health Cancer Center Pilot Projects Grants Funded Throughthe Florida Consortium of National Cancer Institute Center UF Shands Cancer Center Projects UF/Moffitt Collaborative Research Competition Ufscc - Barney Research Ufscc Endowment to Support Cancer Research Ufscc Research Building Equipment Ufscc Startup Umbilical Cord Research Use of Velcade (Bortezomib) in the Treatment of Relapsed Refractory Acute Graft Versus Host Disease (Agvhd) After... Valganciclovir for the Prevention of Late Cmv Infection Afterallogeneic Blood and Marrow Transplantation Variation and Disparity in Prostate Cancer Treatment in the State of Florida Velcade Alone or Velcade Plus Gemcitabine in Previously Treated Paitients with Advanced Non-Small Cell Lung Cancer Viral and Cellular Gene Regulation During Lytic Kshv Winter Fund for Medical Research in the Field of Human Cancer Work Order to the Master Subaward Agreement for Non-Industryfunding Sources Between the Children's Hospital of Philadelp Z05031 - a Phase II Study of Interferon-Based Chemoradiationin Patients With Resected Pancreatic Adenocarcinoma
subcontracts grant Development of a Theoretical Model of Quality of Life for Long-Term Breast Cancer Survivors Living in Rural Areas Grant
UF Department ID 29300000 29300100 29300200 29300300 29300400 29300401 29300402 29300500 29300700 29300800 29300900 29301000
home department for Amlie-Wolf, Louise Non-Academic Anderson, Ashley Research Programs/Services, Coordinator 2 Anderson, Patrick A Non-Academic Ann, Church A Faculty Member Anuszewski, Stephanie M Physician Assistant Basic, Emir Non-Academic Bayne, Ashley Paige RN Specialist -University of Florida Beers, Betsy B Courtesy Faculty Breza, Thomas S,Jr Faculty Member Brown, Lisa Anne Coordinator Research Programs 4 Bruner,Allison Christ Non-Academic Burnham, Jessica L Program Assistant Chan A Shing, Terry F Senior Reg Nurse Cline, Christina L Registered Nurse Cohen, George F Faculty Member Currie, Jessica Ryan Non-Academic Dean, Douglas P Non-Academic Dortch, Christine M Program Assistant Durden, Traci M Administrative Assistant Earl, Vickie Ann Non-Academic Fromowitz, Jeffrey S Medical Doctor Gebhardt, Diane Administrative Assistant Glass,Lewis Frank Faculty Member Greenberg, Myrna Non-Academic Hammock, Diane L Senior Grants Specialist Harada, Naho Non-Academic Harris,Emily Louise Non-Academic Holloway,Kathryn B Consultant Hudson, Chris Non-Academic Huysman, Brynn Assistant Director of Development Ivey, Alison M Sr. Registered Nurse Supervisor Jackson, Cynthia S Financial Coordinator Jones, Cindy A Non-Academic Jones, Stephanie A Sr Fiscal Asst Kobraei, Katherina B Faculty Member Kukulka, Anna Non-Academic LEMOS,BIANCA C Postdoc Lawson, Catherine M Non-Academic Lewis, Melissa A Senior Elec Mic Teaching Lynn, Tracy K Non-Academic Malone,Jaime Ann Non-Academic Malorzo, Wendy Grants Assistant McMeekin,Denise S Non-Academic Mccall, Marjorie D Research RN Merkel, Kimberly Faculty Member Millns, John L Courtesy Faculty Mitchell, Christina Clinical Asst Professor Morales, Daniel J Program Assistant Murphy, Terry Lynn Program Assistant Newsom,Carrie Lynn Non-Academic Nimitz, Carol B Non-Academic Nousari, Carlos H Courtesy Assistant Professor Parks, Jeffrey D Faculty Member Payor, Lucas B Housestaff Pennie, Michelle Faculty Member Pettiford, Leslie C RN Specialist Pittman, Joseph F. Non-Academic Poulos,Evangelos G Consultant Praither, Denise M Ms. Ramos Caro, Francisco A Associate Professor Dermatology Richardson, Diane Non-Academic Rinc, David A Non-Academic Robins, Douglas N Faculty Member Rodriguez, Cecilia Coord Admin Services Rogers, Heather Bergman Non-Academic Sanchez, Fitzgeraldo Faculty Member Sawicki, Barry C Mr Non-Academic Scheraga,Suzanne I Non-Academic Scian, Joanna Non-Academic Sevier, Brian J Assoc Director, Clinical Trials Shaffer, Joshua A HR Coordinator Shapiro, Alexandra M research and services coordinator Starling, Troy W Non-Academic Stokes, Joe Assistant Director Strickland,Traci M Non-Academic Taylor, Tracey Harris Non-Academic Terrell, Joshua Nicholas Non-Academic Thomas, Melissa H Pa Tormes, Kevin Jorge Non-Academic Torres, Sheila M Faculty Member Trainor, Allison Beth Research Project Coordinator Tucker, Caitlin D Non-Academic Tyler, Greg Coordinator Research Programs 4 Veal, David Holiday Protocol Development Assistant Veal, Margaret A Program Assistant Vincek, Vladimir Faculty Member Viviano, Dana L Non-Academic Wesson, Stanton K. Clnasoprf and Prdir Williams, Kevin D Non-Academic Wooten, Matthew C Non-Academic